Valean Darou

What Valean Darou does

Valean Darou (ولیان دارو) is a Tehran-headquartered private pharmaceutical import and distribution company founded in 2015 (Iranian year 1394). It imports finished pharmaceuticals, ophthalmic lenses, and diagnostic-therapeutic medical equipment from international manufacturers and distributes them into Iran's healthcare market. The therapeutic portfolio spans ophthalmology, respiratory, rare diseases, cardiology, pediatrics, oncology, infectious diseases, dermatology, and anesthesiology, with branded specialty products sourced from 14+ global manufacturers including Bausch+Lomb, Recordati, Orphan Europe, JEWIM Pharmaceutical, STADA, Hameln, Aspen, Aop Orphan, Polifarma, Sill, Eumedica, Venture Life, and MITEM PHARMA.

The company operates a nationwide distribution network reaching pharmacies, hospitals, and healthcare professionals. Its commercial model centers on import-margin economics on branded specialty products, particularly ophthalmic intraocular lenses and rare-disease therapies where international supplier partnerships constitute meaningful barriers. Market engagement is conducted through healthcare professional relationships, participation in medical congresses (including the 50th Congress of the Iranian Scientific Optometry Association in September 2025), sponsored training programs (such as the Multifocal Lens Fitting Course in October 2025), and a digital presence on LinkedIn, Instagram, and a corporate website blog.

The company is structured as a private limited company with a self-reported headcount in the 11–50 employee band. It is a pure-play importer-distributor with no disclosed manufacturing, clinical development, or technology platform operations; the core operating capability is regulatory import compliance, supplier relationship management, and last-mile pharmaceutical distribution across Iran.

Name

Valean Darou

Legal name

Valean Darou (ولیان دارو)

Website

https://valeandarou.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Valean Darou (ولیان دارو) is a Tehran-based pharmaceutical importer and distributor founded in 2015 that sources branded specialty medicines, ophthalmic lenses, and medical equipment from 14+ international manufacturers and distributes them to pharmacies, hospitals, and healthcare professionals across Iran.

Ownership category

akta.pro rank

Product category

Pharmaceutical Import and Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Ophthalmic Goods Merchant Wholesalers (423460)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)

akta.pro secondary industries

Specialty Pharmacy & Biologics Distribution (CRAOAHAD), Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)

Keywords

• Pharmaceutical import distribution
• Ophthalmic medications
• Contact lens products
• Rare disease drugs
• Respiratory medications

Headquarters

HQ city

Tehran Dasht

HQ country

Iran

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Product Import and Distribution: Valean Darou generates revenue by importing and distributing a wide range of pharmaceutical products from international manufacturers (including Bausch+Lomb, Recordati, Orphan Europe, JEWIM Pharmaceutical, STADA, Hameln, Eumedica, Polifarma, Sill, Aop Orphan, Aspen, Venture Life, MITEM PHARMA) into Iran. The company serves healthcare providers, pharmacies, and patients across multiple therapeutic categories including ophthalmology, respiratory, rare diseases, cardiology, pediatrics, oncology, infectious diseases, dermatology, and anesthesiology.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Valean Darou is a pharmaceutical importer and distributor that brings specialty medications, ophthalmic products, contact lenses, and medical foods from leading international manufacturers into the Iranian market. The company operates a curated portfolio across therapeutic areas including ophthalmology, respiratory care, rare diseases, oncology, cardiology, pediatrics, anesthesia, psychiatry, infectious disease, and dermatology. It supports this portfolio with physician-facing ordering tools, patient support programs, and pharmacovigilance services, distributing products through pharmacies, hospitals, and direct engagement with healthcare professionals across Iran.

Product overview

Valean Darou (ولیان دارو) is an Iranian pharmaceutical import and distribution company established in 2015. The company serves as the official importer of a diverse portfolio of pharmaceutical products and medical devices from world-renowned manufacturers including Bausch+Lomb, Recordati, STADA, Hameln, Eumedica, Polifarma, JEWIM Pharmaceutical, Sill, Aop Orphan, Aspen, Venture Life, and MITEM Pharma. Their product portfolio spans multiple therapeutic categories: ophthalmology (contact lenses including Ultra, Purevision, Purevision 2, Purevision 2 MF, Purevision 2 Toric, Soflens, and colored Tri Kolor lenses; artificial tears like Artelac Advanced and Liposic; prescription medications including Latanoprost, Lotemax, and ReNu MultiPlus wetting drops), respiratory (Salmeterol/Fluticasone and Fluticasone), rare diseases/orphan drugs (Cystadane, Cystadrop, Cystagone, Carbaglu, Qarziba, Pedea), pediatrics/infant nutrition (Vitalae Advanced, Vitalae AR, Vitalae LF), cardiology (Amiodarone, Thromboreductin, Trisuva, Dobutamine, Digoxin), blood and cancer (ARA-CELL, Ifosfamide, BLEO-CELL, Doxorubicin, Cellcristin, Mesna, Gelclair), infectious diseases (Negaban), dermatology (Meladinine), anesthesia (Propofol, Dopram, Flumazenil, Marcaine), and psychiatry (Orap, Orap Forte). The company also provides patient support programs, drug information services, and adverse event reporting. Valean Darou maintains partnerships with international pharmaceutical companies and participates in scientific events to advance ophthalmology and optometry knowledge in Iran.

Differentiator

Problem solved

Functional benefit

Products and services

• Ophthalmic Pharmaceuticals (Artificial Tears, Glaucoma, Anti-inflammatory Eye Drops) Prescription and over-the-counter ophthalmic medications including artificial tears (Artelac Advanced, Liposic), prostaglandin analog for glaucoma (Latanoprost), corticosteroid for post-surgical inflammation (Lotemax), and lubricating/rewetting drops (ReNu MultiPlus). Targeted at ophthalmologists, optometrists, pharmacies, and patients in Iran requiring dry eye management, glaucoma treatment, or post-operative care.
• Contact Lenses (Bausch+Lomb portfolio) Soft contact lenses including Ultra, Ultra MF (multifocal), Ultra Toric (astigmatism), Purevision, Purevision 2, Purevision 2 MF (presbyopia), Purevision 2 Toric (astigmatism), Soflens 59 (daily wear), Soflens Daily (daily disposable), and Tri Kolor (colored). Distributed through optometrists and pharmacies in Iran.
• Contact Lens Care Solutions Contact lens cleaning, disinfecting, and storage solutions including Biotrue multi-purpose solution. Targeted at contact lens wearers in Iran purchasing through pharmacies and optical retailers.
• Rare Disease / Orphan Drugs (Recordati portfolio) Orphan drugs for rare metabolic, genetic, and lysosomal storage disorders including Cystadane (homocystinuria), Cystadrop (cystinosis), Cystagone (nephropathic cystinosis), Carbaglu (hyperammonemia), Qarziba / dinutuximab beta (high-risk neuroblastoma in children), and Pedea. Targeted at specialist physicians, hospital pharmacies, and Iranian patients with rare diseases.
• Respiratory Medications (JEWIM Pharmaceutical) Respiratory medications including Salmeterol/Fluticasone combination (LABA/ICS) and standalone Fluticasone corticosteroid for asthma, COPD, and allergic rhinitis. Targeted at pulmonologists, respiratory specialists, and pharmacies in Iran.
• Oncology / Hematology Pharmaceuticals Chemotherapy and supportive care medications including ARA-CELL (cytarabine), Ifosfamide, BLEO-CELL (bleomycin), Doxorubicin, Cellcristin (vincristine), and Mesna (chemoprotective agent for hemorrhagic cystitis prevention). Targeted at oncologists, hospital pharmacies, and oncology centers in Iran.
• Cardiology Pharmaceuticals Cardiovascular medications including Amiodarone (antiarrhythmic), Dobutamine (inotropic for acute heart failure), Digoxin (Lanoxin, cardiac glycoside), Trisuva, and Thromboreductin (for essential thrombocythemia). Targeted at cardiologists, hospital pharmacies, and patients with cardiac conditions in Iran.
• Pediatric Medical Nutrition (Sill infant formulas) Specialized infant formulas including Vitalae Advanced (preterm 0-6 months), Vitalae AR (anti-reflux 0+ months), and Vitalae AR (anti-reflux 6-12 months). Targeted at pediatricians, neonatologists, pharmacies, and parents of infants with specialized nutritional needs in Iran.
• Anesthesia Pharmaceuticals Anesthetic and peri-operative medications including Propofol (induction and maintenance of anesthesia), Dopram / doxapram (respiratory stimulant for anesthesia recovery), Flumazenil (benzodiazepine antagonist), and Marcaine / bupivacaine (long-acting local anesthetic). Targeted at anesthesiologists, hospital pharmacies, and surgical centers in Iran.
• Psychiatry Pharmaceuticals

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

13 partnerships are on record, tiered core and supporting.

• Bausch+LombcoreOthersValean Darou partners with Bausch+Lomb, a world-renowned company in the production of ophthalmic pharmaceutical products. Through this partnership, the company imports a range of eye care products including contact lenses (Ultra, Purevision, Soflens), artificial tears (Artelac), and eye drops (ReNu MultiPlus, Latanoprost, Lotemax) for the Iranian market.
• RecordaticoreOthersRecordati is a leading pharmaceutical company specializing in products for patients with rare diseases. Valean Darou imports Recordati's orphan drugs including Cystadane, Cystadrop, Cystagone, and Pedea for Iranian patients suffering from rare medical conditions.
• JEWIM PHARMACEUTICALcoreOthersJEWIM PHARMACEUTICAL is a pharmaceutical company specializing in respiratory products. Valean Darou imports respiratory medications including Salmeterol/Fluticasone combination and Fluticasone from JEWIM for Iranian patients.
• Orphan Europe (Recordati Rare Diseases)coreOthersOrphan Europe, part of the Recordati group, is a pioneer in developing pharmaceutical products for patients with rare diseases. Valean Darou partners with Orphan Europe to bring rare disease treatments to Iran.
• STADAsupportingOthersSTADA is a partner pharmaceutical company whose products are distributed by Valean Darou in Iran. One identified product is ARA-CELL (Cytarabine), an oncology medication.
• HamelnsupportingOthersHameln is a pharmaceutical company supplying injectable medications. Valean Darou imports Amiodarone injection from Hameln for cardiac arrhythmia treatment in the Iranian market.
• EumedicasupportingOthersEumedica is a pharmaceutical company specializing in psychiatric medications. Valean Darou imports Orap (Pimozide) from Eumedica for the Iranian psychiatric pharmaceutical market.
• PolifarmasupportingOthersPolifarma is a pharmaceutical company supplying anesthetic products. Valean Darou imports Propofol from Polifarma for anesthetic use in Iranian medical facilities.
• SillsupportingOthersSill is a pharmaceutical company specializing in pediatric nutrition products. Valean Darou imports Vitalae infant formulas from Sill for the Iranian pediatric market.
• Aop OrphansupportingOthersAop Orphan is a pharmaceutical company focused on rare and orphan diseases. Valean Darou imports Thromboreductin from Aop Orphan for Iranian patients.
• AspensupportingOthersAspen is a global pharmaceutical company. Valean Darou imports Lanoxin (Digoxin) from Aspen for cardiac treatment in Iran.
• Venture LifesupportingOthersVenture Life is a pharmaceutical company. Valean Darou imports Gelclair from Venture Life for the Iranian market.
• MITEM PHARMAsupportingOthersMITEM PHARMA supplies dermatological products. Valean Darou imports Meladinine from MITEM PHARMA for skin treatment in Iran.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Others

• Bausch + Lomb: Global ophthalmic pharmaceutical and contact lens manufacturer; primary supplier-partner for Valean Darou's ophthalmology franchise. While not a peer in the distribution sense, Bausch+Lomb's go-to-market strategy in Iran (via Valean Darou as importer) is structurally tied to the company's success and is the dominant share-of-mind comparable in the ophthalmology channel.
• Recordati Rare Diseases: Specialty pharmaceutical division of Recordati focused on rare disease treatments; one of Valean Darou's principal partners. While not a competitor (Recordati is a supplier, not a distributor in Iran), it is a key strategic reference point — Valean Darou's distribution rights for Recordati/Orphan Europe orphan drugs in Iran define its rare disease franchise.

Broad incumbents

• Hikma Pharmaceuticals: Jordan-headquartered specialty pharmaceutical company with branded generics, injectables, and licensing/distribution partnerships across the Middle East and North Africa. Comparable to Valean Darou in the specialty pharma distribution model, therapeutic area overlap (ophthalmology, oncology, respiratory), and emerging-market focus — though Hikma also manufactures and operates at significantly larger scale.
• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer with regional MENA distribution networks across multiple therapeutic categories including ophthalmology. Comparable to Valean Darou in the Middle East regional pharma distribution model and therapeutic breadth, but with significantly larger manufacturing and distribution infrastructure.
• SPIMACO Addwaeih: Saudi Arabian pharmaceutical manufacturer and distributor with regional MENA presence across branded generics, licensing, and distribution. Comparable to Valean Darou in the import-partner-led specialty distribution model and Middle East regional positioning, with broader manufacturing capabilities and geographic footprint.

Direct peers

• Barakat Pharmaceutical Group: Iranian state-affiliated pharmaceutical group involved in import, distribution, and partial manufacturing of essential and specialty medicines. Comparable to Valean Darou in the import-distribution business model and B2B sales to pharmacies, but operates with policy-driven scale advantages and broader category coverage.
• Cobel Darou: Iranian pharmaceutical importer and distributor working with international principals to serve Iranian pharmacies and hospitals. Directly comparable to Valean Darou in operating model (import-partner-led specialty distribution), therapeutic breadth, and customer segments, competing for the same Iranian healthcare provider wallet.
• Darou Pakhsh Pharmaceutical: One of Iran's largest pharmaceutical manufacturers and distributors, operating in both domestic manufacturing and importation/distribution across multiple therapeutic categories. Directly comparable to Valean Darou in the import-and-distribute-to-pharmacies/hospitals business model, though at significantly larger scale and with a manufacturing footprint Valean Darou lacks.
• Tofigh Darou: Iranian pharmaceutical import and distribution company with a multi-category portfolio covering ophthalmology, respiratory, and specialty therapeutics. Closely comparable to Valean Darou in business model (import-led, B2B distribution), therapeutic focus overlap, and target customer base (pharmacies, hospitals, physicians in Iran).
• Razak Pharmaceutical Laboratories: Iranian pharmaceutical company with import and distribution operations across multiple therapeutic categories including ophthalmology. Comparable to Valean Darou in import-and-distribute focus, B2B go-to-market, and concentration on the Iranian market, with overlapping therapeutic-area coverage.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks3 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/valean-darou
• Instagraminstagram.com/valeandarou

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Valean Darou